Albemarle Corporation (ALB) has been experiencing fluctuating stock prices, with periods of sliding and steep jumps as the market rises. Various analysts have issued raised price targets. Notably, Albemarle sold a controlling stake in
Ketjen to KPS Capital Partners and also sold Ketjen stock to ChemCat. The company continues to pay regular dividends, further attracting investor attention. In terms of asset management, Sumitomo Mitsui Trust Group Inc. sold ALB shares while Pacific Heights Asset Management LLC increased its position.
Lithium price recovery signals brighter prospects, marking a potential turnaround, which Deutsche Bank, Baird, and KayBanc have noted. Short interest has risen in the materials stock. The firm is also navigating
US-China tensions with significant price implications in the rare earth stocks market. Analysts have issued various recommendations, from strong buy to neutral and sell. With a significant price increase, some wonder if Albemarle Corporation is a buy now or if its stock is undergoing a valuation bubble. Finally, major corporate actions such as strategic restructuring, sale of stake in units, coupled with earnings release, have shaped Albemarle's stocks overall market position.
Albemarle Stocks ALB News Analytics from Tue, 25 Feb 2025 08:00:00 GMT to Fri, 31 Oct 2025 11:58:54 GMT -
Rating 3
- Innovation 5
- Information 8
- Rumor 7
